Dengue - Sustainable Large Scale Vaccine Delivery in Low-Income Markets (A): The Challenges of Vaccine Launches in Emerging Markets

Published 25 Jan 2016
Reference 6165
Industry Farming
Region Other Regions
Length 3 page(s)

This case explores the difficulties involved in commercialising vaccines in low-income settings. The focus is the dengue vaccine, launched at the end of 2015, which was first commercialised in emerging markets. It considers issues of affordability and distribution, highlighting the need for business model innovation in all industries.

Teaching objectives

- Identify key decision makers in a market with multiple stakeholders - Understand the need to focus on demand (rather than cost-cutting alone) when supplying the BOP - Exploring the pros and cons of extra-industry and public-private partnerships

  • Vaccines
  • Business Model Innovation
  • Dengue
  • Drug delivery
  • Bottom of the pyramid
  • Intrapreneurship
  • Pharmaceuticals
  • Emerging Markets
  • Q21516
  • HMI
  • Pharmaceutical and Medical Device Sectors